Chemical pathology of homocysteine. II. Carcinogenesis and homocysteine thiolactone metabolism

Abnormalities of methionine metabolism in malignancy include carcinogenicity of methionine deficiency, methionine auxotrophy of cultured malignant cells, deficient methylation of DNA, and aerobic glycolysis that is reversed by methionine. Cells from children with homocystinuria form an aggregated sulfated extracellular matrix and grow in a pattern similar to cultured malignant cells. Normal cells metabolize homocysteine thiolactone to sulfate, but malignant cells accumulate homocysteine thiolactone, which thiolates proteins and other cellular macromolecules. Thioretinamide, the amide of retinoic acid homocysteine thiolactone, and its cobalamin complex, thioretinaco, are antineoplastic and chemopreventive against carcinogenesis. Deficiency of these compounds in malignant cells is believed to increase conversion of methionine to homocysteine thiolactone and thioco, its cobalamin complex. These compounds are believed to participate in oxidative phosphorylation by formation of thioretinaco ozonide disulfonium complexes that are the active sites of adenosine triphosphate (ATP) binding in mitochondrial membranes. Hypothetical deficiency of thioretinaco may explain important metabolic abnormalities of malignant cells.

This article has been cited by other articles:

				K. S McCully Reply to EZ Soliman and OA Shalash Am. J. Clinical Nutrition, April 1, 2008; 87(4): 1070 - 1071. [Full Text] [PDF]

				K. S McCully Homocysteine, vitamins, and vascular disease prevention Am. J. Clinical Nutrition, November 1, 2007; 86(5): 1563S - 1568S. [Abstract] [Full Text] [PDF]

				N. Li, F.-X. Yi, E. Rute, D. X. Zhang, G. R. Slocum, and A.-P. Zou Effects of homocysteine on intracellular nitric oxide and superoxide levels in the renal arterial endothelium Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1237 - H1243. [Abstract] [Full Text] [PDF]

				R.-F. S. Huang, S.-M. Huang, B.-S. Lin, C.-Y. Hung, and H.-T. Lu N-Acetylcysteine, Vitamin C and Vitamin E Diminish Homocysteine Thiolactone-Induced Apoptosis in Human Promyeloid HL-60 Cells J. Nutr., August 1, 2002; 132(8): 2151 - 2156. [Abstract] [Full Text] [PDF]

				K. R Dimitrova, K. DeGroot, A. K Myers, and Y. D Kim Estrogen and homocysteine Cardiovasc Res, February 15, 2002; 53(3): 577 - 588. [Abstract] [Full Text] [PDF]

				G. N. Welch and J. Loscalzo Homocysteine and Atherothrombosis N. Engl. J. Med., April 9, 1998; 338(15): 1042 - 1050. [Full Text] [PDF]

				K. S. McCully Homocysteine, Folate, Vitamin B6, and Cardiovascular Disease JAMA, February 4, 1998; 279(5): 392 - 393. [Full Text] [PDF]

				G. Liu, K. Nellaiappan, and H. M. Kagan Irreversible Inhibition of Lysyl Oxidase by Homocysteine Thiolactone and Its Selenium and Oxygen Analogues. IMPLICATIONS FOR HOMOCYSTINURIA J. Biol. Chem., December 19, 1997; 272(51): 32370 - 32377. [Abstract] [Full Text] [PDF]

				A. Majors, L. A. Ehrhart, and E. H. Pezacka Homocysteine as a Risk Factor for Vascular Disease : Enhanced Collagen Production and Accumulation by Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 2074 - 2081. [Abstract] [Full Text]